Astrocytoma
Showing 26 - 50 of 748
Astrocytoma, Oligodendroglioma, Adult, Glioma, Malignant Trial in Saint Louis (temporally-modulated pulsed radiotherapy (TMPRT))
Recruiting
- Astrocytoma
- +2 more
- temporally-modulated pulsed radiotherapy (TMPRT)
-
Saint Louis, MissouriWashington University School of Medicine
Jan 19, 2023
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)
Recruiting
- Diffuse Astrocytoma
- +22 more
-
Phoenix, Arizona
- +26 more
Jan 27, 2023
Recurrent Glioblastoma, Recurrent Astrocytoma, Recurrent Oligodendroglioma Trial in Oklahoma City (Niraparib)
Recruiting
- Recurrent Glioblastoma
- +3 more
-
Oklahoma City, OklahomaStephenson Cancer Center
Jul 20, 2022
Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)
Active, not recruiting
- Glioma, Malignant
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2022
Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)
Active, not recruiting
- Glioblastoma Multiforme of Brain
- +2 more
- C134
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Sep 19, 2022
Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Astrocytoma, Grade IV Trial in Ann Arbor (drug, radiation, procedure)
Recruiting
- Recurrent Glioblastoma
- +5 more
- Mycophenolate Mofetil
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jul 7, 2022
Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 8, 2022
Glioma, Pilocytic Astrocytoma, Anaplastic Astrocytoma Trial in Saint Louis (MRI-guided laser ablation, Doxorubicin, Etoposide)
Recruiting
- Glioma
- +8 more
- MRI-guided laser ablation
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 22, 2022
High-grade Glioma, Oligodendroglioma, Astrocytoma Trial (Low-dose OKN-007, BID, Low-dose OKN-007, TID, Mid-dose OKN-007, TID)
Not yet recruiting
- High-grade Glioma
- +3 more
- Low-dose OKN-007, BID
- +3 more
- (no location specified)
Sep 26, 2022
Loupe-Based Intraoperative Fluorescence Imaging
Recruiting
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
-
Lexington, KentuckyUniversity of Kentucky
Mar 3, 2022
Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)
Not yet recruiting
- Glioma
- +3 more
- Retifanlimab
- All-trans retinoic acid
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 22, 2022
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Astrocytoma, Grade III Trial in San Antonio, Zuerich (Debio 0123,
Not yet recruiting
- Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
- Astrocytoma, Grade III
- Debio 0123
- +2 more
-
San Antonio, Texas
- +1 more
Mar 9, 2023
Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)
Completed
- Malignant Glioma
- +3 more
- Dendritic Cell Vaccine
- +3 more
-
Miami, FloridaUniversity of Miami
Jul 19, 2022
Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after
Active, not recruiting
- Oligodendroglioma
- +5 more
- GBM6-AD and poly-ICLC before and after surgery
- GBM6-AD and poly-ICLC after surgery only
-
San Francisco, CaliforniaUniversity of California
Sep 20, 2022
Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)
Terminated
- Glioblastoma Multiforme
- +3 more
-
Indianapolis, IndianaRiley Hospital for Children at IU Health
Jul 21, 2022
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,
Active, not recruiting
- Adult Anaplastic Astrocytoma
- +15 more
- biopsy
- +7 more
-
Rochester, MinnesotaMayo Clinic
Apr 8, 2022
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab and Carboplatin)
Suspended
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Bevacizumab and Carboplatin
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 27, 2021
Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,
Recruiting
- Glioblastoma
- +3 more
- Nivolumab-Placebo
- +4 more
-
Los Angeles, California
- +3 more
Jan 16, 2023
Glioblastomas, Sarcoma, Astrocytoma Trial run by the NCI (Enhanced Mindfulness Intervention, Psychoeducation)
Completed
- Glioblastomas
- +4 more
- Enhanced Mindfulness Intervention
- Psychoeducation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 14, 2022
Recurrent Glioblastoma Trial in Portland (TVI-Brain 1)
Available
- Recurrent Glioblastoma
- TVI-Brain 1
-
Portland, OregonProvidence St. Vincent Medical Center
Jun 28, 2023
Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)
Active, not recruiting
- Glioblastoma
- +3 more
- Stereotactic Radiosurgery
-
Lake Success, New YorkNorthwell Health Brain Tumor Center
Feb 3, 2022
Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in
Active, not recruiting
- Recurrent Glioblastoma Multiforme
- +2 more
- M032 (NSC 733972)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 26, 2022